-
201
Hybrid optimal control for HIV multi-drug therapies: A finite set control transcription approach
Published 2012-09-01“…In this study, the treatment of Human Immunodeficiency Virus (HIV) infection is investigated through an optimal structured treatment interruption (STI) schedule of two classes of antiretroviral drugs, mainly, reverse transcriptase inhibitors and protease inhibitors. …”
Get full text
Article -
202
Pneumocystis carinii Pneumonia in HIV — Investigate or Just Treat?
Published 1994-01-01“…Pneumocystis carinii pneumonia (PCP) is an extremely common manifistation of the acquired immunodeficiency syndrome (AIDS) resulting from infection with the human immunodeficiency virus (HIV). Most episodes present in a fairly typical manner with increased dyspnea and/or a nonproductive cough, a diffuse interstitial pattern on chest readiograph and an elevated alveolar-arterial oxygen gradient. …”
Get full text
Article -
203
A Review of Electroanalytical Techniques for Determination of Anti-HIV Drugs
Published 2011-01-01“…Until now after the human immunodeficiency virus (HIV) was discovered as the then tentative aetiological agent of acquired immune deficiency syndrome (AIDS), exactly 25 anti-HIV compounds have been formally approved for clinical use in the treatment of AIDS. …”
Get full text
Article -
204
Undiagnosed HIV Presenting with Lymphoid Interstitial Pneumonitis
Published 2011-01-01“…Undiagnosed or untreated human immunodeficiency virus infection can lead to devastating complications. …”
Get full text
Article -
205
Regulation of viral replication by host restriction factors
Published 2025-01-01“…Viral infectious diseases, caused by numerous viruses including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A virus (IAV), enterovirus (EV), human immunodeficiency virus (HIV), hepatitis B virus (HBV), and human papillomavirus (HPV), pose a continuous threat to global health. …”
Get full text
Article -
206
Guillain–Barre syndrome: An atypical presentation of IRIS on initiation of antiretroviral therapy in a newly diagnosed HIV infected
Published 2024-12-01“…We report the occurrence of Guillain–Barre syndrome (GBS) along with disseminated histoplasmosis in a 45-year-old male who had tested seropositive for human immunodeficiency virus (HIV). Histoplasmosis was treated with conventional amphotericin B followed by oral itraconazole. …”
Get full text
Article -
207
Phytochemistry, Pharmacology and Toxicology of Spilanthes acmella: A Review
Published 2013-01-01“…Literature survey proposed that it has multiple pharmacological actions, which include antifungal, antipyretic, local anaesthetic, bioinsecticide, anticonvulsant, antioxidant, aphrodisiac, analgesic, pancreatic lipase inhibitor, antimicrobial, antinociception, diuretic, vasorelaxant, anti-human immunodeficiency virus, toothache relieve and anti-inflammatory effects. …”
Get full text
Article -
208
Sexual Transmission of Hepatitis B virus: Epidemiological Considerations and Implications for Control with Vaccine
Published 1991-01-01“…Specific interventions designed to prevent sexual transmission of human immunodeficiency virus (eg. testing for infection status and counselling, choosing partners carefully, avoiding prostitutes, use of condoms, and diagnostic and treatment services for other sexually transmitted diseases) should further reduce hepatitis B virus sexual transmission in men and women. …”
Get full text
Article -
209
Microencapsulation Techniques in HIV Pediatric Formulations: Advances and Future Outlook
Published 2024-01-01“…The treatment of human immunodeficiency virus (HIV) in children has persistently been complex and tedious on a global scale. …”
Get full text
Article -
210
Pneumocystis Prophylaxis for All, Some, or No HIV-infected Infants Less than One Year of Age: A Decision Analysis Approach
Published 1993-01-01“…Pneumocystis carinii pneumonia (PCP) is associated with significant mortality and morbidity among infants infected with human immunodeficiency virus (HIV). The preferred prophylaxis strategy for such infants is a subject of debate. …”
Get full text
Article -
211
Primary Esophageal Lymphoma: A Histopathological Experience from Two Tertiary Hospitals, Western Saudi Arabia
Published 2023-01-01“…None of the patients were immunocompromised or had human immunodeficiency virus (HIV) infection. The clinical manifestation included dysphagia and loss of weight. …”
Get full text
Article -
212
The critical role of primary care clinicians in the early detection of ocular surface squamous neoplasia
Published 2025-02-01“…Its rising incidence, primarily driven by the human immunodeficiency virus (HIV) epidemic, presents significant challenges in clinical diagnosis, as these lesions often share characteristics with other conjunctival lesions. …”
Get full text
Article -
213
The occupational roles of hospitalized people due to Acquired Immune Deficiency Syndrome
Published 2014-04-01“…Persons hosting Human Immunodeficiency Virus (HIV) and patients having Acquired Immunodeficiency Syndrome (AIDS) suffer from alterations of occupational roles. …”
Get full text
Article -
214
Fatal Outcome of Disseminated Strongyloidiasis despite Detectable Plasma and Cerebrospinal Levels of Orally Administered Ivermectin
Published 2009-01-01“…Those people most susceptible to infection are those with an immunocompromising condition, such as cancer or human immunodeficiency virus (HIV). Local disease may spread throughout the body of the host, causing a condition termed disseminated strongyloidiasis. …”
Get full text
Article -
215
Coinfections increase the risk of HIV acquisition, AIDS progression, and therapy and prophylaxis failure: a review
Published 2024-08-01“… Few people exposed to human immunodeficiency virus (HIV) become infected. Among those infected, the rate of progression to full-blown acquired immunodeficiency syndrome (AIDS) and susceptibility to various opportunistic infections varies widely as does their response to antiretroviral therapies (ARTs). …”
Get full text
Article -
216
Extensive Inactive Neurocysticercosis: A Case Report in Mbeya, Southern Highlands of Tanzania
Published 2025-01-01“…So far, little is known about how Human Immunodeficiency Virus (HIV) co-infection modifies clinical NCC presentation. …”
Get full text
Article -
217
Analysis of HIV therapy in the liver using optimal control and pharmacokinetics
Published 2025-01-01“…Abstract The main burden in treating human immunodeficiency virus (HIV) infection currently, is the side effects of the antiretroviral therapy (ART) used, because each treatment is toxic to the liver. …”
Get full text
Article -
218
Pneumocystis carinii: A Review of an Important Opportunistic Pathogen in AIDS
Published 1991-01-01“…Individuals with damaged T helper cells secondary to malignancies (eg, Hodgkin’s lymphoma), drugs (eg, cyclosporine, steroids), or certain infections (eg, human immunodeficiency virus) are at particular risk. Serological studies suggest that disease is most often secondary to the reactivation of an asymptomatic infection, usually acquired during childhood. …”
Get full text
Article -
219
HIV-Related Immune Activation and Inflammation: Current Understanding and Strategies
Published 2021-01-01“…Although antiretroviral therapy effectively controls human immunodeficiency virus (HIV) replication, a residual chronic immune activation/inflammation persists throughout the disease. …”
Get full text
Article -
220
Autoimmune Hepatitis (AIH) in Acquired Immune Deficiency Syndrome (AIDS): A Case Report and Review of Literature
Published 2019-01-01“…The common causes of abnormal liver chemistries in human immunodeficiency virus (HIV) infected patients are multifactorial. …”
Get full text
Article